Search Results 1991-2000 of 20076 for Receptor
Concomitant use of angiotensin-converting-enzyme inhibitor (ACEi) or angiotensin receptor blocker (ARB) at stable doses for at least 2 weeks or have intolerance ...
... receptor (VEGFR) (e.g., sunitinib, pazopanib, sorafenib, tivozanib, cabozantinib). One prior immunotherapy (interleukin-2 or interferon-alpha or immune ...
... receptor modifiers; aromatase inhibitors; GnRH analogs; androgens or antiandrogens; Concurrent use of warfarin and strong inhibitors or CYP2D6 will not be ...
Angiotensin receptor plus neprilysin inhibitors (ARNIs). This medicine uses two blood pressure medicines to treat heart failure. The combination medicine is ...
... receptor mediated transcription program providing therapeutic escape. FEBS Open Bio. 2024 Nov; 14 (11):1873-1887 Epub 2024 Sept 19. View PubMed; Conboy CB ...
Patients have orthoptics, thyroid function tests, a TSH receptor antibody test and an orbital CT prescheduled for the same day. The latter is set for the ...
... receptor expressing (SSTR+) gastroenteropancreatic neuroendocrine tumors (GEP-NETs) that have progressed following treatment with Lutetium 177-labelled ...
Exploring the Role of B-cell Activating Factor Receptor (BAFFR)-based Chimeric Antigen Receptor T-cell (CAR T) in BAFFR-expressing B-cell Hematologic ...
Phagocytosis entails the recognition and engulfment of microbes by numerous cell surface receptors. Particle recognition is accompanied by polymerization of ...
On a clinically relevant and stable dose of an angiotensin converting-enzyme inhibitor (ACEI) OR an angiotensin receptor blocker (ARB), unless not tolerated or ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.